Literature DB >> 28511254

Genetic Forms of Parkinson's Disease.

Christine Y Kim1, Roy N Alcalay2.   

Abstract

One of the greatest advances in Parkinson's disease (PD) research in the past two decades has been a better understanding of PD genetics. Of the many candidate genes investigated, the best studied include LRRK2, SNCA, VPS35, Parkin, PINK1, and DJ1. The authors review the key clinical features of these monogenic forms, as well as for the prevalent risk factor gene, GBA, including the phenotype, clinical course, and treatment response. They also outline areas for future investigation: longitudinal studies of PD's clinical course, the identification of its premotor manifestations, and its specific mechanisms of pathogenicity. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2017        PMID: 28511254     DOI: 10.1055/s-0037-1601567

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  31 in total

Review 1.  The protective role of exercise against age-related neurodegeneration.

Authors:  Alyson Sujkowski; Luke Hong; R J Wessells; Sokol V Todi
Journal:  Ageing Res Rev       Date:  2021-12-17       Impact factor: 10.895

Review 2.  Parkinson's Disease: A Multisystem Disorder.

Authors:  Helena Nunes Costa; Ana Raquel Esteves; Nuno Empadinhas; Sandra Morais Cardoso
Journal:  Neurosci Bull       Date:  2022-08-22       Impact factor: 5.271

3.  A quantitative systems pharmacology model for simulating OFF-Time in augmentation trials for Parkinson's disease: application to preladenant.

Authors:  Rachel Rose; Emma Mitchell; Piet Van Der Graaf; Daisuke Takaichi; Jun Hosogi; Hugo Geerts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-10-09       Impact factor: 2.410

4.  Evaluation of Mitochondrial Function and Morphology in Drosophila.

Authors:  Yinglu Tang; Foozhan Tahmasebinia; Zhihao Wu
Journal:  Methods Mol Biol       Date:  2021

5.  UBE2M Is a Stress-Inducible Dual E2 for Neddylation and Ubiquitylation that Promotes Targeted Degradation of UBE2F.

Authors:  Weihua Zhou; Jie Xu; Mingjia Tan; Haomin Li; Hua Li; Wenyi Wei; Yi Sun
Journal:  Mol Cell       Date:  2018-06-21       Impact factor: 17.970

6.  Lysosome and Inflammatory Defects in GBA1-Mutant Astrocytes Are Normalized by LRRK2 Inhibition.

Authors:  Anwesha Sanyal; Mark P DeAndrade; Hailey S Novis; Steven Lin; Jianjun Chang; Nathalie Lengacher; Julianna J Tomlinson; Malú G Tansey; Matthew J LaVoie
Journal:  Mov Disord       Date:  2020-02-08       Impact factor: 10.338

Review 7.  Genetic Testing for Parkinson Disease: Are We Ready?

Authors:  Lola Cook; Jeanine Schulze; Catherine Kopil; Tara Hastings; Anna Naito; Joanne Wojcieszek; Katelyn Payne; Roy N Alcalay; Christine Klein; Rachel Saunders-Pullman; Tatyana Simuni; Tatiana Foroud
Journal:  Neurol Clin Pract       Date:  2021-02

Review 8.  Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain.

Authors:  Lorenzo Gaetani; Lucilla Parnetti; Paolo Calabresi; Massimiliano Di Filippo
Journal:  Front Neurosci       Date:  2021-05-24       Impact factor: 4.677

9.  The commercial genetic testing landscape for Parkinson's disease.

Authors:  Lola Cook; Jeanine Schulze; Jennifer Verbrugge; James C Beck; Karen S Marder; Rachel Saunders-Pullman; Christine Klein; Anna Naito; Roy N Alcalay
Journal:  Parkinsonism Relat Disord       Date:  2021-10-19       Impact factor: 4.891

10.  Serum lipid profile among sporadic and familial forms of Parkinson's disease.

Authors:  Daniel Macías-García; María Teresa Periñán; Laura Muñoz-Delgado; María Valle Jimenez-Jaraba; Miguel Ángel Labrador-Espinosa; Silvia Jesús; Dolores Buiza-Rueda; Carlota Méndez-Del Barrio; Astrid Adarmes-Gómez; Pilar Gómez-Garre; Pablo Mir
Journal:  NPJ Parkinsons Dis       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.